Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterol regulatory element-binding transcription factor 1a (SREBP-1a) is an isoform of SREBP-1, a key transcription factor regulating genes involved in lipid and cholesterol synthesis. SREBP-1a originates from the SREBF1 gene by alternative promoter usage and is broadly expressed, including in the intestine and spleen. It exerts its function by binding sterol regulatory elements (SREs) in the promoters of genes controlling lipid biosynthesis, thus playing a central role in metabolic regulation. SREBP-1a is synthesized as an ER/nuclear membrane-bound precursor and is activated via proteolytic cleavage in response to low sterol levels, releasing the active domain into the nucleus. Dysregulation of SREBP-1a is implicated in diseases characterized by altered lipid metabolism, including non-alcoholic fatty liver disease, metabolic syndrome, and various cancers[1][2][5].
Modulation of SREBP-1a activation (through inhibition of cleavage/activation or influencing upstream regulators); Alteration of SREBP-1a transcriptional activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterol regulatory element-binding transcription factor 1a (SREBP-1a).